Summit Trail Advisors LLC Sells 421 Shares of Doximity, Inc. (NASDAQ:DOCS)

Summit Trail Advisors LLC decreased its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 0.8% during the fourth quarter, HoldingsChannel reports. The fund owned 52,932 shares of the company’s stock after selling 421 shares during the quarter. Summit Trail Advisors LLC’s holdings in Doximity were worth $1,484,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in Doximity by 5.9% during the 3rd quarter. Vanguard Group Inc. now owns 11,038,475 shares of the company’s stock worth $234,236,000 after purchasing an additional 616,157 shares during the period. Baillie Gifford & Co. lifted its position in shares of Doximity by 0.9% during the third quarter. Baillie Gifford & Co. now owns 6,656,242 shares of the company’s stock valued at $141,245,000 after buying an additional 57,078 shares during the last quarter. Bank of New York Mellon Corp grew its position in shares of Doximity by 9.6% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,229,750 shares of the company’s stock worth $26,095,000 after buying an additional 107,776 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Doximity by 10.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 699,066 shares of the company’s stock valued at $14,834,000 after acquiring an additional 67,363 shares in the last quarter. Finally, AQR Capital Management LLC increased its stake in Doximity by 344.2% during the 3rd quarter. AQR Capital Management LLC now owns 540,126 shares of the company’s stock valued at $11,461,000 after purchasing an additional 418,523 shares in the last quarter. 87.19% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts recently issued reports on DOCS shares. Wells Fargo & Company raised their target price on Doximity from $25.00 to $27.00 and gave the stock an “equal weight” rating in a research note on Friday, February 9th. Bank of America increased their price target on shares of Doximity from $29.00 to $32.00 and gave the stock a “neutral” rating in a report on Tuesday, January 23rd. Evercore ISI restated an “in-line” rating and set a $30.00 target price on shares of Doximity in a research report on Tuesday, April 2nd. Leerink Partnrs reaffirmed a “market perform” rating on shares of Doximity in a report on Monday, February 26th. Finally, Truist Financial boosted their price objective on Doximity from $28.00 to $29.00 and gave the company a “hold” rating in a research report on Friday, February 9th. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $28.82.

Insider Buying and Selling at Doximity

In related news, Director Kira Scherer Wampler sold 2,500 shares of Doximity stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $26.97, for a total value of $67,425.00. Following the sale, the director now directly owns 10,258 shares in the company, valued at $276,658.26. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 39.40% of the stock is owned by corporate insiders.

Doximity Trading Up 2.1 %

NASDAQ:DOCS traded up $0.51 during midday trading on Monday, hitting $24.60. 944,303 shares of the company were exchanged, compared to its average volume of 1,688,288. Doximity, Inc. has a fifty-two week low of $19.71 and a fifty-two week high of $36.29. The company has a market capitalization of $4.59 billion, a PE ratio of 37.27, a price-to-earnings-growth ratio of 3.03 and a beta of 1.18. The company has a fifty day simple moving average of $26.45 and a 200 day simple moving average of $26.32.

Doximity (NASDAQ:DOCS) last released its quarterly earnings results on Thursday, February 8th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.19 by $0.06. Doximity had a return on equity of 16.08% and a net margin of 29.39%. The company had revenue of $135.28 million for the quarter, compared to analyst estimates of $127.46 million. As a group, equities research analysts expect that Doximity, Inc. will post 0.72 EPS for the current year.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.